arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

SHOULDER INNOVATIONS, INC.

SI
$20.69 ▼ -0.36 (-1.71%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
11 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

SHOULDER INNOVATIONS, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $429.0M
Dividend Yield —
Revenue Growth 56.0% ↘
Op. Margin -58.4% ↘
ROIC -7.2% ↘
FCF / Share $-0.46 ↗
Trailing P/E —
Price / Book 3.5x
FCF Yield —
Debt / Equity 0.12
info Valuation on last close. End-of-day price, Nov 5, 2026.

11-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$17.18M
↑ +56.0% —
Net Income Profit after all expenses
$-8.38M
↓ -79.7% —
Operating Margin Operating profit as % of sales
-58.4%
↓ -8.8% 5th
FCF / Share Free cash flow per share
$-0.46
↑ +37.0% —
Long-Term Debt Long-term obligations
$14.81M
↓ -1.0% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
4
Returns
24
Financial Health ↓
54
Cash Quality ↓
60

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 3 years · 11 quarters